Impact of Bariatric Surgery on Carotid Artery Inflammation and the Metabolic Activity in Different Adipose Tissues

Medicine (United States)

Volumn 94, Issue 20, 2015, Pages

  Bucerius, Jan ^a,b   Vijgen, Guy H E J ^c,d   Brans, Boudewijn ^a   Bouvy, Nicole D ^d   Bauwens, Matthias ^a,c   Rudd, James H F ^e   Havekes, Bas ^c   Fayad, Zahi A ^f,g   Van Marken Lichtenbelt, Wouter D ^c   Mottaghy, Felix M ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f Zena and Michael A Weiner Cardiovascular Institute   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADIPOSE TISSUE; ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BARIATRIC SURGERY; BROWN ADIPOSE TISSUE; CAROTID ARTERY; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; INFLAMMATION; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MALE; METABOLIC ACTIVATION; MOLECULAR IMAGING; MORBID OBESITY; PET-CT SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ARTERITIS; CAROTID ARTERY DISEASE; METABOLISM; OBESITY, MORBID; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADULT; ARTERITIS; BARIATRIC SURGERY; CAROTID ARTERY DISEASES; FEMALE; HUMANS; MALE; OBESITY, MORBID; POSITRON-EMISSION TOMOGRAPHY;

EID: 84937965764     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000725     Document Type: Article

References (37)

1. Tirosh A, Shai I, Afek A, et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med. 2011;364:1315-1325.
2. Sjöström L, Lindroos AK, Peltonen M, et al., Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
3. James WP, Caterson ID, Coutinho W, et al., SCOUT Investigators. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363:905-917.
4. Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001;21:323-341.
5. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. J Am Med Assoc. 2012;307:56-65.
6. Nissen SE, Nicholls SJ, Wolski K, et al., STRADIVARIUS Investigators. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. J Am Med Assoc. 2008;299:1547-1560.
7. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416-423.
8. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.
9. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002;105:2696-2698.
10. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-880.
11. Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605-613.
12. Greif M, Becker A, von Ziegler F, et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:781-786.
13. Ouellet V, Labbe SM, Blondin DP, et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest. 2012;122:545-552.
14. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360:1518-1525.
15. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500-1508.
16. Chang L, Villacorta L, Li R, et al. Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-g deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation. 2012;126:1067-1078.
17. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18Ffluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-1824.
18. Pedersen SF, Graebe M, Fisker Hag AM, et al. Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun. 2010;31:423-429.
19. Vijgen GH, Bouvy ND, Teule GJ, et al. Brown adipose tissue in morbidly obese subjects. PLoS One. 2011;6:e17247.
20. Vijgen GH, Bouvy ND, Teule GJ, et al. Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2012;97:E1229-E1233.
21. Christen T, Sheikine Y, Rocha VZ, et al. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. JACC Cardiovasc Imaging. 2010;3:843-851.
22. von Elm E, Altman DG, Egger M, et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-1457.
23. Rudd JH, Myers KS, Bansilal S, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-878.
24. Bucerius J, Duivenvoorden R, Mani V, et al. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. JACC Cardiovasc Imaging. 2011;4:1195-1205.
25. Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959-2971.
26. Fitzgibbons TP, Kogan S, Aouadi M, et al. Similarity of mouse perivascular and brown adipose tissues and their resistance to dietinduced inflammation. Am J Physiol Heart Circ Physiol. 2011;301:H1425-H1437.
27. Viana EC, Araujo-Dasilio KL, Miguel GP, et al. Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-a. Prospective Clinical Trial. Obes Surg. 2013;23:1252-1261.
28. Ruiz-Tovar J, Oller I, Galindo I, et al. Change in levels of Creactive protein (CRP) and serum cortisol in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg. 2013;23:764-769.
29. Brunken R, Freire M, Neumann D. Visceral fat volume is unrelated to adipose tissue inflammation. J Nucl Cardiol. 2008;15:S7(Abstract).
30. Getz GS. Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis. J Lipid Res. 2005;46:1-10.
31. Tacke F, Alvarez D, Kaplan TJ, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007;117:185-194.
32. Swirski FK, Libby P, Aikawa E, et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195-205.
33. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
34. Bucerius J, Mani V, Wong S, et al. Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study. Eur J Nucl Med Mol Imaging. 2014;41:934-945.
35. Kortelainen ML. Association between cardiac pathology and fat tissue distribution in an autopsy series of men without premortem evidence of cardiovascular disease. Int J Obes Relat Metab Disord. 1996;20:245-252.
36. Gunawardana SC, Piston DW. Reversal of type 1 diabetes in mice by brown adipose tissue transplant. Diabetes. 2012;61:674-682.
37. Bucerius J, Mani V, Moncrieff C, et al. Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med Mol Imaging. 2014;41:369-383.